Tuesday, March 14 2006 14:35 Hrs (IST) - World Time -

Bangalore: Biocon, India's largest bio-tech firm, is developing drugs for cancer and diabetes that could be 'potentially blockbusters', says its Chairman and Managing Director Kiran Mazumdar-Shaw.

"Well, I just think that I would love to develop a blockbuster drug with `Made in India' label from our company",said Mazumdar-Shaw, the country's richest businesswoman, when asked about her dream.

And is the company working towards that?

"Yes, we have a very interesting research pipeline. We are developing a number of products which could be potentially blockbusters", she told sources.

"But it's not something that can be predicted. Research is a very unpredictable business. If it happens it's a huge bonanza; if it doesn't, it's a huge lot of money," she added.

She said the drugs she was talking about were in the areas of cancer and diabetes.

"Most of these products will take at least two to four years before you can even think of accessing the markets," she said.

Responding to questions, Mazumdar-Shaw admits that stress is part of life when one runs a business of Biocon's magnitude. Stock market expectations to keep performing and outperforming every quarter puts constant pressure on her.

"Right now, all of us get very stressed by business-related matters", she said, when asked if she gets a good night's sleep or if business-related matters keep coming back to her mind.